MedDataX Logo

Post-Marketing Surveillance of Micombi Tablets Survey on the Long-term Use

NCT ID: NCT01050062

Last Updated: 2014-05-01

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1452 participants

Study Classification

OBSERVATIONAL

Study Start Date

2010-01-31

Study Completion Date

2011-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The survey is conducted to collect safety and effectiveness information in Hypertensive patients treated with Micombi Tablets on the long term use in daily clinical settings in Japan.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

To Evaluate Real-world Safety, Effectiveness and Appropriate Use of Micatrio® Combination Tablets Treatment in Patients With Hypertension

NCT03021265

Hypertension
COMPLETED

Safety and Efficacy of Daily Use of Micamlo® Combination Tablets AP in Patients With Hypertension

NCT01353274

Hypertension
COMPLETED

Filtered Trial for Telmisartan 40mg Non-responder

NCT00550953

Hypertension
COMPLETED PHASE3

3 x 3 Factorial Trial of Telmisartan and Hydrochlorothiazide in Patients With Essential Hypertension

NCT00153049

Hypertension
COMPLETED PHASE2

Trial of Telmisartan 80 mg/HCTZ 12.5 mg and Telmisartan 40 mg/HCTZ 12.5 mg in Patients With Hypertension

NCT00326768

Hypertension
COMPLETED PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypertension

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Micombi® Combination Tablet AP

Telmisartan 40mg

Intervention Type DRUG

Combination tablet

Hydrochlorothiazide 12.5mg

Intervention Type DRUG

Combination tablet

Micombi® Combination Tablet BP

Telmisartan 80mg

Intervention Type DRUG

Combination tablet

Hydrochlorothiazide 12.5mg

Intervention Type DRUG

Combination tablet

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Telmisartan 80mg

Combination tablet

Intervention Type DRUG

Telmisartan 40mg

Combination tablet

Intervention Type DRUG

Hydrochlorothiazide 12.5mg

Combination tablet

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Hypertensive patients who have never taken Micombi Tablets.

Exclusion Criteria

None
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Astellas Pharma Inc

INDUSTRY

Sponsor Role collaborator

Boehringer Ingelheim

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Boehringer Ingelheim

Role: STUDY_CHAIR

Boehringer Ingelheim

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Boehringer Ingelheim Investigational Site 111

Ageo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 209

Aisho-cho, , Japan

Site Status

Boehringer Ingelheim Investigational Site 22

Aizubange-machi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 234

Akashi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 78

Akiruno, , Japan

Site Status

Boehringer Ingelheim Investigational Site 79

Akishima, , Japan

Site Status

Boehringer Ingelheim Investigational Site 235

Akō, , Japan

Site Status

Boehringer Ingelheim Investigational Site 288

Akune, , Japan

Site Status

Boehringer Ingelheim Investigational Site 236

Amagasaki, , Japan

Site Status

Boehringer Ingelheim Investigational Site 237

Amagasaki, , Japan

Site Status

Boehringer Ingelheim Investigational Site 280

Anan, , Japan

Site Status

Boehringer Ingelheim Investigational Site 160

Anjo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 1

Asahikawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site 51

Ashikaga, , Japan

Site Status

Boehringer Ingelheim Investigational Site 140

Atsugi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 58

Azumino, , Japan

Site Status

Boehringer Ingelheim Investigational Site 128

Chiba, , Japan

Site Status

Boehringer Ingelheim Investigational Site 138

Chiba, , Japan

Site Status

Boehringer Ingelheim Investigational Site 141

Chigasaki, , Japan

Site Status

Boehringer Ingelheim Investigational Site 299

Chikujo-machi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 44

Chikusei, , Japan

Site Status

Boehringer Ingelheim Investigational Site 80

Chōfu, , Japan

Site Status

Boehringer Ingelheim Investigational Site 311

Ebino, , Japan

Site Status

Boehringer Ingelheim Investigational Site 257

Fuchū, , Japan

Site Status

Boehringer Ingelheim Investigational Site 71

Fuefuki, , Japan

Site Status

Boehringer Ingelheim Investigational Site 179

Fujieda, , Japan

Site Status

Boehringer Ingelheim Investigational Site 211

Fujiidera, , Japan

Site Status

Boehringer Ingelheim Investigational Site 112

Fukaya, , Japan

Site Status

Boehringer Ingelheim Investigational Site 206

Fukui, , Japan

Site Status

Boehringer Ingelheim Investigational Site 300

Fukuoka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 301

Fukuoka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 302

Fukuoka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 303

Fukuoka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 180

Fukuroi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 23

Fukushima, , Japan

Site Status

Boehringer Ingelheim Investigational Site 258

Fukuyama, , Japan

Site Status

Boehringer Ingelheim Investigational Site 129

Funabashi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 47

Funaishikawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site 174

Gifu, , Japan

Site Status

Boehringer Ingelheim Investigational Site 175

Gifu, , Japan

Site Status

Boehringer Ingelheim Investigational Site 42

Gonohe-machi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 113

Gyōda, , Japan

Site Status

Boehringer Ingelheim Investigational Site 212

Habikino, , Japan

Site Status

Boehringer Ingelheim Investigational Site 81

Hachiōji, , Japan

Site Status

Boehringer Ingelheim Investigational Site 82

Hachiōji, , Japan

Site Status

Boehringer Ingelheim Investigational Site 193

Hakusan, , Japan

Site Status

Boehringer Ingelheim Investigational Site 181

Hamamatsu, , Japan

Site Status

Boehringer Ingelheim Investigational Site 247

Hashimoto, , Japan

Site Status

Boehringer Ingelheim Investigational Site 142

Hatano, , Japan

Site Status

Boehringer Ingelheim Investigational Site 259

Hatsukaichi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 114

Higashi-Matsuyama, , Japan

Site Status

Boehringer Ingelheim Investigational Site 276

Higashikagawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site 83

Higashikurume, , Japan

Site Status

Boehringer Ingelheim Investigational Site 213

Higashiosaka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 84

Hino, , Japan

Site Status

Boehringer Ingelheim Investigational Site 43

Hirosaki, , Japan

Site Status

Boehringer Ingelheim Investigational Site 260

Hiroshima, , Japan

Site Status

Boehringer Ingelheim Investigational Site 261

Hiroshima, , Japan

Site Status

Boehringer Ingelheim Investigational Site 262

Hiroshima, , Japan

Site Status

Boehringer Ingelheim Investigational Site 263

Hiroshima, , Japan

Site Status

Boehringer Ingelheim Investigational Site 45

Hitachi-Naka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 72

Hokuto, , Japan

Site Status

Boehringer Ingelheim Investigational Site 266

Hōfu, , Japan

Site Status

Boehringer Ingelheim Investigational Site 249

Ibara, , Japan

Site Status

Boehringer Ingelheim Investigational Site 214

Ibaraki, , Japan

Site Status

Boehringer Ingelheim Investigational Site 215

Ibaraki, , Japan

Site Status

Boehringer Ingelheim Investigational Site 130

Ichikawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site 161

Ichinomiya, , Japan

Site Status

Boehringer Ingelheim Investigational Site 18

Ichinoseki, , Japan

Site Status

Boehringer Ingelheim Investigational Site 19

Ichinoseki, , Japan

Site Status

Boehringer Ingelheim Investigational Site 59

Ina, , Japan

Site Status

Boehringer Ingelheim Investigational Site 289

Isa, , Japan

Site Status

Boehringer Ingelheim Investigational Site 187

Ise, , Japan

Site Status

Boehringer Ingelheim Investigational Site 74

Isesaki, , Japan

Site Status

Boehringer Ingelheim Investigational Site 182

Itō, , Japan

Site Status

Boehringer Ingelheim Investigational Site 52

Iwafune-machi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 24

Iwaki, , Japan

Site Status

Boehringer Ingelheim Investigational Site 162

Iwakura, , Japan

Site Status

Boehringer Ingelheim Investigational Site 216

Izumisano, , Japan

Site Status

Boehringer Ingelheim Investigational Site 194

Kaga, , Japan

Site Status

Boehringer Ingelheim Investigational Site 290

Kagoshima, , Japan

Site Status

Boehringer Ingelheim Investigational Site 73

Kai, , Japan

Site Status

Boehringer Ingelheim Investigational Site 195

Kanazawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site 53

Kanuma, , Japan

Site Status

Boehringer Ingelheim Investigational Site 163

Kariya, , Japan

Site Status

Boehringer Ingelheim Investigational Site 238

Kasai, , Japan

Site Status

Boehringer Ingelheim Investigational Site 164

Kasugai, , Japan

Site Status

Boehringer Ingelheim Investigational Site 115

Kasukabe, , Japan

Site Status

Boehringer Ingelheim Investigational Site 217

Kawachi-Nagano, , Japan

Site Status

Boehringer Ingelheim Investigational Site 116

Kawaguchi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 117

Kawaguchi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 231

Kawaichō, , Japan

Site Status

Boehringer Ingelheim Investigational Site 143

Kawasaki, , Japan

Site Status

Boehringer Ingelheim Investigational Site 144

Kawasaki, , Japan

Site Status

Boehringer Ingelheim Investigational Site 145

Kawasaki, , Japan

Site Status

Boehringer Ingelheim Investigational Site 296

Kawatana-cho, , Japan

Site Status

Boehringer Ingelheim Investigational Site 40

Kazuno, , Japan

Site Status

Boehringer Ingelheim Investigational Site 29

Kesennuma, , Japan

Site Status

Boehringer Ingelheim Investigational Site 131

Kisarazu, , Japan

Site Status

Boehringer Ingelheim Investigational Site 2

Kitahiroshima, , Japan

Site Status

Boehringer Ingelheim Investigational Site 304

Kitakyushu, , Japan

Site Status

Boehringer Ingelheim Investigational Site 305

Kitakyushu, , Japan

Site Status

Boehringer Ingelheim Investigational Site 306

Kitakyushu, , Japan

Site Status

Boehringer Ingelheim Investigational Site 239

Kobe, , Japan

Site Status

Boehringer Ingelheim Investigational Site 240

Kobe, , Japan

Site Status

Boehringer Ingelheim Investigational Site 241

Kobe, , Japan

Site Status

Boehringer Ingelheim Investigational Site 242

Kobe, , Japan

Site Status

Boehringer Ingelheim Investigational Site 118

Koshigaya, , Japan

Site Status

Boehringer Ingelheim Investigational Site 277

Kotohira, , Japan

Site Status

Boehringer Ingelheim Investigational Site 25

Kōriyama, , Japan

Site Status

Boehringer Ingelheim Investigational Site 119

Kumagaya, , Japan

Site Status

Boehringer Ingelheim Investigational Site 291

Kumamoto, , Japan

Site Status

Boehringer Ingelheim Investigational Site 292

Kumamoto, , Japan

Site Status

Boehringer Ingelheim Investigational Site 284

Kunisaki, , Japan

Site Status

Boehringer Ingelheim Investigational Site 250

Kurashiki, , Japan

Site Status

Boehringer Ingelheim Investigational Site 264

Kure, , Japan

Site Status

Boehringer Ingelheim Investigational Site 265

Kure, , Japan

Site Status

Boehringer Ingelheim Investigational Site 285

Kusu-machi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 197

Kyoto, , Japan

Site Status

Boehringer Ingelheim Investigational Site 198

Kyoto, , Japan

Site Status

Boehringer Ingelheim Investigational Site 199

Kyoto, , Japan

Site Status

Boehringer Ingelheim Investigational Site 200

Kyoto, , Japan

Site Status

Boehringer Ingelheim Investigational Site 85

Machida, , Japan

Site Status

Boehringer Ingelheim Investigational Site 307

Maebaru, , Japan

Site Status

Boehringer Ingelheim Investigational Site 146

Matsuda-machi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 132

Matsudo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 60

Matsumoto, , Japan

Site Status

Boehringer Ingelheim Investigational Site 61

Matsumoto, , Japan

Site Status

Boehringer Ingelheim Investigational Site 272

Matsuyama, , Japan

Site Status

Boehringer Ingelheim Investigational Site 273

Matsuyama, , Japan

Site Status

Boehringer Ingelheim Investigational Site 188

Matsuzaka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 293

Minamata, , Japan

Site Status

Boehringer Ingelheim Investigational Site 30

Minamisanriku, , Japan

Site Status

Boehringer Ingelheim Investigational Site 218

Minoo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 46

Mito, , Japan

Site Status

Boehringer Ingelheim Investigational Site 312

Miyazaki, , Japan

Site Status

Boehringer Ingelheim Investigational Site 133

Mobara, , Japan

Site Status

Boehringer Ingelheim Investigational Site 20

Morioka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 26

Motomiya, , Japan

Site Status

Boehringer Ingelheim Investigational Site 3

Mukawa-cho, , Japan

Site Status

Boehringer Ingelheim Investigational Site 86

Musashino, , Japan

Site Status

Boehringer Ingelheim Investigational Site 62

Nagano, , Japan

Site Status

Boehringer Ingelheim Investigational Site 63

Nagano, , Japan

Site Status

Boehringer Ingelheim Investigational Site 297

Nagasaki, , Japan

Site Status

Boehringer Ingelheim Investigational Site 165

Nagoya, , Japan

Site Status

Boehringer Ingelheim Investigational Site 166

Nagoya, , Japan

Site Status

Boehringer Ingelheim Investigational Site 167

Nagoya, , Japan

Site Status

Boehringer Ingelheim Investigational Site 168

Nagoya, , Japan

Site Status

Boehringer Ingelheim Investigational Site 192

Nagoya, , Japan

Site Status

Boehringer Ingelheim Investigational Site 314

Naha, , Japan

Site Status

Boehringer Ingelheim Investigational Site 41

Nakadōri, , Japan

Site Status

Boehringer Ingelheim Investigational Site 54

Nakagawamachi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 176

Nakatsugawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site 196

Nanao, , Japan

Site Status

Boehringer Ingelheim Investigational Site 278

Nankoku, , Japan

Site Status

Boehringer Ingelheim Investigational Site 232

Nara, , Japan

Site Status

Boehringer Ingelheim Investigational Site 31

Natori, , Japan

Site Status

Boehringer Ingelheim Investigational Site 4

Nayoro, , Japan

Site Status

Boehringer Ingelheim Investigational Site 313

Nichinan, , Japan

Site Status

Boehringer Ingelheim Investigational Site 65

Niigata, , Japan

Site Status

Boehringer Ingelheim Investigational Site 66

Niigata, , Japan

Site Status

Boehringer Ingelheim Investigational Site 147

Ninomiya-machi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 243

Nishinomiya, , Japan

Site Status

Boehringer Ingelheim Investigational Site 244

Nishinomiya, , Japan

Site Status

Boehringer Ingelheim Investigational Site 169

Nishio, , Japan

Site Status

Boehringer Ingelheim Investigational Site 87

Nishitōkyō, , Japan

Site Status

Boehringer Ingelheim Investigational Site 5

Obihiro, , Japan

Site Status

Boehringer Ingelheim Investigational Site 255

Oda, , Japan

Site Status

Boehringer Ingelheim Investigational Site 189

Odai-cho, , Japan

Site Status

Boehringer Ingelheim Investigational Site 148

Odawara, , Japan

Site Status

Boehringer Ingelheim Investigational Site 294

Ogi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 251

Okayama, , Japan

Site Status

Boehringer Ingelheim Investigational Site 252

Okayama, , Japan

Site Status

Boehringer Ingelheim Investigational Site 253

Okayama, , Japan

Site Status

Boehringer Ingelheim Investigational Site 308

Omuta, , Japan

Site Status

Boehringer Ingelheim Investigational Site 309

Omuta, , Japan

Site Status

Boehringer Ingelheim Investigational Site 219

Osaka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 220

Osaka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 221

Osaka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 222

Osaka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 223

Osaka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 224

Osaka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 225

Osaka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 226

Osaka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 6

Otaru, , Japan

Site Status

Boehringer Ingelheim Investigational Site 55

Oyama, , Japan

Site Status

Boehringer Ingelheim Investigational Site 16

Ōdate, , Japan

Site Status

Boehringer Ingelheim Investigational Site 286

Ōita, , Japan

Site Status

Boehringer Ingelheim Investigational Site 287

Ōita, , Japan

Site Status

Boehringer Ingelheim Investigational Site 21

Ōshū, , Japan

Site Status

Boehringer Ingelheim Investigational Site 210

Ōtsu, , Japan

Site Status

Boehringer Ingelheim Investigational Site 75

Ōuramachi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 67

Sado, , Japan

Site Status

Boehringer Ingelheim Investigational Site 149

Sagamihara, , Japan

Site Status

Boehringer Ingelheim Investigational Site 150

Sagamihara, , Japan

Site Status

Boehringer Ingelheim Investigational Site 274

Saijō, , Japan

Site Status

Boehringer Ingelheim Investigational Site 120

Saitama, , Japan

Site Status

Boehringer Ingelheim Investigational Site 121

Saitama, , Japan

Site Status

Boehringer Ingelheim Investigational Site 122

Saitama, , Japan

Site Status

Boehringer Ingelheim Investigational Site 227

Sakai, , Japan

Site Status

Boehringer Ingelheim Investigational Site 228

Sakai, , Japan

Site Status

Boehringer Ingelheim Investigational Site 229

Sakai, , Japan

Site Status

Boehringer Ingelheim Investigational Site 39

Sakata, , Japan

Site Status

Boehringer Ingelheim Investigational Site 134

Sakura, , Japan

Site Status

Boehringer Ingelheim Investigational Site 68

Sanjō, , Japan

Site Status

Boehringer Ingelheim Investigational Site 135

Sanmu, , Japan

Site Status

Boehringer Ingelheim Investigational Site 267

Sanyōonoda, , Japan

Site Status

Boehringer Ingelheim Investigational Site 268

Sanyōonoda, , Japan

Site Status

Boehringer Ingelheim Investigational Site 10

Sapporo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 11

Sapporo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 12

Sapporo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 7

Sapporo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 8

Sapporo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 9

Sapporo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 298

Sasebo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 123

Satte, , Japan

Site Status

Boehringer Ingelheim Investigational Site 124

Sayama, , Japan

Site Status

Boehringer Ingelheim Investigational Site 32

Sendai, , Japan

Site Status

Boehringer Ingelheim Investigational Site 33

Sendai, , Japan

Site Status

Boehringer Ingelheim Investigational Site 34

Sendai, , Japan

Site Status

Boehringer Ingelheim Investigational Site 35

Sendai, , Japan

Site Status

Boehringer Ingelheim Investigational Site 36

Sendai, , Japan

Site Status

Boehringer Ingelheim Investigational Site 37

Sendai, , Japan

Site Status

Boehringer Ingelheim Investigational Site 69

Shibata, , Japan

Site Status

Boehringer Ingelheim Investigational Site 13

Shibetsu, , Japan

Site Status

Boehringer Ingelheim Investigational Site 125

Shiki, , Japan

Site Status

Boehringer Ingelheim Investigational Site 279

Shimanto, , Japan

Site Status

Boehringer Ingelheim Investigational Site 310

Shime-machi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 183

Shimoda, , Japan

Site Status

Boehringer Ingelheim Investigational Site 248

Shingū, , Japan

Site Status

Boehringer Ingelheim Investigational Site 38

Shiraishi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 136

Shiroi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 184

Shizuoka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 185

Shizuoka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 269

Shūnan, , Japan

Site Status

Boehringer Ingelheim Investigational Site 126

Sōka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 27

Sukagawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site 190

Suzuka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 88

Tachikawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site 203

Takaoka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 204

Takaoka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 245

Takarazuka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 76

Takasaki, , Japan

Site Status

Boehringer Ingelheim Investigational Site 77

Takasaki, , Japan

Site Status

Boehringer Ingelheim Investigational Site 177

Takayama, , Japan

Site Status

Boehringer Ingelheim Investigational Site 246

Tatsuno, , Japan

Site Status

Boehringer Ingelheim Investigational Site 170

Tokoname, , Japan

Site Status

Boehringer Ingelheim Investigational Site 127

Tokorozawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site 281

Tokushima, , Japan

Site Status

Boehringer Ingelheim Investigational Site 282

Tokushima, , Japan

Site Status

Boehringer Ingelheim Investigational Site 89

Tokyo Adachi-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site 90

Tokyo Adachi-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site 102

Tokyo Bunkyo-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site 91

Tokyo Chiyoda-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site 92

Tokyo Chiyoda-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site 93

Tokyo Kita-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site 94

Tokyo Koto-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site 95

Tokyo Meguro-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site 96

Tokyo Meguro-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site 97

Tokyo Nerima-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site 98

Tokyo Ota-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site 99

Tokyo Ota-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site 100

Tokyo Setagaya-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site 101

Tokyo Setagaya-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site 103

Tokyo Shibuya-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site 104

Tokyo Shinagawa-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site 105

Tokyo Shinagawa-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site 106

Tokyo Shinagawa-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site 107

Tokyo Shinjuku-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site 108

Tokyo Suginami-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site 109

Tokyo Sumida-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site 110

Tokyo Toshima-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site 14

Tomakomai, , Japan

Site Status

Boehringer Ingelheim Investigational Site 28

Tomioka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 295

Tosu, , Japan

Site Status

Boehringer Ingelheim Investigational Site 270

Tottori, , Japan

Site Status

Boehringer Ingelheim Investigational Site 15

Toyako-machi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 205

Toyama, , Japan

Site Status

Boehringer Ingelheim Investigational Site 171

Toyohashi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 172

Toyokawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site 230

Toyonaka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 173

Toyota, , Japan

Site Status

Boehringer Ingelheim Investigational Site 70

Tōkamachi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 49

Tsuchiura, , Japan

Site Status

Boehringer Ingelheim Investigational Site 207

Tsuruga, , Japan

Site Status

Boehringer Ingelheim Investigational Site 208

Tsuruga, , Japan

Site Status

Boehringer Ingelheim Investigational Site 283

Tsurugi-cho, , Japan

Site Status

Boehringer Ingelheim Investigational Site 254

Tsuyama, , Japan

Site Status

Boehringer Ingelheim Investigational Site 64

Ueda, , Japan

Site Status

Boehringer Ingelheim Investigational Site 201

Uji, , Japan

Site Status

Boehringer Ingelheim Investigational Site 48

Ushiku, , Japan

Site Status

Boehringer Ingelheim Investigational Site 56

Utsunomiya, , Japan

Site Status

Boehringer Ingelheim Investigational Site 57

Utsunomiya, , Japan

Site Status

Boehringer Ingelheim Investigational Site 275

Uwajima, , Japan

Site Status

Boehringer Ingelheim Investigational Site 137

Yachimata, , Japan

Site Status

Boehringer Ingelheim Investigational Site 186

Yaizu, , Japan

Site Status

Boehringer Ingelheim Investigational Site 178

Yamagata, , Japan

Site Status

Boehringer Ingelheim Investigational Site 151

Yamato, , Japan

Site Status

Boehringer Ingelheim Investigational Site 233

Yamatokooriyama, , Japan

Site Status

Boehringer Ingelheim Investigational Site 191

Yokkaichi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 152

Yokohama, , Japan

Site Status

Boehringer Ingelheim Investigational Site 153

Yokohama, , Japan

Site Status

Boehringer Ingelheim Investigational Site 154

Yokohama, , Japan

Site Status

Boehringer Ingelheim Investigational Site 155

Yokohama, , Japan

Site Status

Boehringer Ingelheim Investigational Site 156

Yokohama, , Japan

Site Status

Boehringer Ingelheim Investigational Site 157

Yokohama, , Japan

Site Status

Boehringer Ingelheim Investigational Site 158

Yokohama, , Japan

Site Status

Boehringer Ingelheim Investigational Site 159

Yokosuka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 271

Yonago, , Japan

Site Status

Boehringer Ingelheim Investigational Site 202

Yosano-cho, , Japan

Site Status

Boehringer Ingelheim Investigational Site 256

Yoshika-cho, , Japan

Site Status

Boehringer Ingelheim Investigational Site 139

Yotsukaidō, , Japan

Site Status

Boehringer Ingelheim Investigational Site 17

Yurihonjō, , Japan

Site Status

Boehringer Ingelheim Investigational Site 50

Yūki, , Japan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Japan

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

502.542

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Evaluation of Effect of Combination With Telmisartan and Hydrochlorothiazide in Hypertensives Uncontrolled on Amlodipine
NCT00509470 COMPLETED PHASE4
An Open-label, Long-term Study of Telmisartan Plus Amlodipine Fixed-dose Combination
NCT00618774 COMPLETED PHASE3
Combination of Telmisartan 40 mg Plus Hydrochlorothiazide (HCTZ) 12.5 mg vs. Telmisartan 40 mg Alone in Patients With Essential Hypertension Who Fail to Respond Adequately to Telmisartan Monotherapy
NCT00144222 COMPLETED PHASE3
Survey to Assess Why People Are Not Responding to Treatment in Hypertension
NCT01071681 COMPLETED
Add-on to Micamlo BP Trial
NCT01975246 COMPLETED PHASE3
Nice Morning- Safety and Efficacy Observational Study of Telmisartan in Hypertensive Patients in Multicenters
NCT00615108 COMPLETED
Post-Marketing Surveillance of Micardis® (Telmisartan) in Patients With Hypertension
NCT02242838 COMPLETED
A Randomized, Double-blind, Parallel-group Assessment of the Safety and Efficacy of Telmisartan 40mg Plus Hydrochlorothiazide 12.5mg (Micardis Plus) in Comparison With Losartan 50mg Plus Hydrochlorothiazide 12.5mg in Taiwanese Patients With Mild to Moderate Hypertension
NCT00133185 COMPLETED PHASE3
Compare Efficacy and Safety of Telmisartan/Hydrochlorothiazide With Telmisartan/Hydrochlorothiazide Plus Amlodipine
NCT01911780 COMPLETED PHASE3
Telmisartan and Hydrochlorothiazide Antihypertensive Treatment Study in High Sodium Intake Population
NCT02255253 COMPLETED NA
Micardis® in Patients With Essential Hypertension
NCT02187705 COMPLETED
J-TARGET,Japanese Telmisartan Study for Antihypertensive Good Effect in Long Term Observation
NCT00659581 COMPLETED
Comparison in Japan T80/A5 (Telmisartan 80 mg and Amlodipine 5 mg) and T40/A5 (Telmisartan 40 mg and Amlodipine 5 mg)
NCT01286558 COMPLETED PHASE3
Pharmacokinetics of Different Formulations of Telmisartan, Amlodipine, and Hydrochlorothiazide (HCTZ) in Japanese Healthy Male Volunteers
NCT02183675 COMPLETED PHASE1
Open Label Study Telmisartan and Amlodipine in Hypertension
NCT00614380 COMPLETED PHASE3
Filtered Trial for Amlodipine Non-responder
NCT00558064 COMPLETED PHASE3
A Bioequivalence Study Between Telmione 80 mg and Micardis 80 mg in Healthy Adult Volunteers
NCT05223101 UNKNOWN PHASE1
26-week Open Study of telmisartan40mg+amlodipine10mg or telmisartan80mg+amlodipine10 mg in Hypertension
NCT00624052 COMPLETED PHASE3
Evaluation of Efficacy and Tolerability of Micardis® / MicardisPlus® Under Usual Daily-practice Prescribing in Patients With Hypertension
NCT02242383 COMPLETED
Comparison of the Medication Adherence of Patients Treated With Telmisartan/Hydrochlorothiazide or Telmisartan/Amlodipine Fixed Dose Combination (FDC) Versus Double-pill Combination Therapy in Real-world Japanese Therapeutic Practice
NCT03205137 WITHDRAWN
Study to Evaluate the Trough and Peak Effect of Once Daily Telmisartan 80 mg/Hydrochlorothiazide 12.5 mg (Micardis Plus) by Ambulatory Blood Pressure Monitoring (ABPM) in Patients With Mild to Moderate Essential Hypertension
NCT00257491 COMPLETED PHASE3
Efficacy and Safety of GMRx2 Compared to Dual Combinations for the Treatment of Hypertension
NCT04518293 COMPLETED PHASE3
An Observational Study to Investigate the Efficacy, Safety, Tolerability and the Effect on Quality of Life of Telmisartan (Micardis) and Telmisartan With HCTZ (Micardis Plus) in Patients With Hypertension
NCT00904215 COMPLETED
Telmisartan 80mg Non-responder Trial
NCT01222520 COMPLETED PHASE3
INTERVENCION Trial
NCT02373163 COMPLETED PHASE4